171 related articles for article (PubMed ID: 33303019)
21. An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability
Urbano PCM; Koenen HJPM; Joosten I; He X
Front Immunol; 2018; 9():573. PubMed ID: 29619032
[TBL] [Abstract][Full Text] [Related]
22. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4
Chen S; Li R; Chen Y; Chou CK; Zhang Z; Yang Y; Liao P; Wang Q; Chen X
Biomed Pharmacother; 2022 Jul; 151():113187. PubMed ID: 35676787
[TBL] [Abstract][Full Text] [Related]
23. Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients.
Govindaraj C; Madondo M; Kong YY; Tan P; Wei A; Plebanski M
Am J Hematol; 2014 Aug; 89(8):795-802. PubMed ID: 24757092
[TBL] [Abstract][Full Text] [Related]
24. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.
Chen X; Subleski JJ; Kopf H; Howard OM; Männel DN; Oppenheim JJ
J Immunol; 2008 May; 180(10):6467-71. PubMed ID: 18453563
[TBL] [Abstract][Full Text] [Related]
25. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE.
Tsakiri N; Papadopoulos D; Denis MC; Mitsikostas DD; Kollias G
Eur J Immunol; 2012 Feb; 42(2):403-12. PubMed ID: 22105853
[TBL] [Abstract][Full Text] [Related]
26. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.
Govindaraj C; Scalzo-Inguanti K; Madondo M; Hallo J; Flanagan K; Quinn M; Plebanski M
Clin Immunol; 2013 Oct; 149(1):97-110. PubMed ID: 23948613
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
Front Immunol; 2017; 8():1482. PubMed ID: 29163543
[TBL] [Abstract][Full Text] [Related]
28. TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways.
Markel TA; Crisostomo PR; Wang M; Wang Y; Lahm T; Novotny NM; Tan J; Meldrum DR
Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1124-30. PubMed ID: 18685063
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4
He T; Yang D; Li XQ; Jiang M; Islam MS; Chen S; Chen Y; Yang Y; Chou CK; Trivett AL; Oppenheim JJ; Chen X
Sci Adv; 2020 Sep; 6(40):. PubMed ID: 32998896
[TBL] [Abstract][Full Text] [Related]
30. TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.
Moatti A; Debesset A; Pilon C; Beldi-Ferchiou A; Leclerc M; Redjoul R; Charlotte F; To NH; Bak A; Belkacemi Y; Salomon BL; Issa F; Michonneau D; Maury S; Cohen JL; Thiolat A
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387779
[TBL] [Abstract][Full Text] [Related]
31. Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3
Yu Y; Valderrama AV; Han Z; Uzan G; Naserian S; Oberlin E
Stem Cell Res Ther; 2021 Feb; 12(1):138. PubMed ID: 33597011
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells can induce regulatory T cells via modulating miR-126a but not miR-10a.
Khosravi M; Karimi MH; Hossein Aghdaie M; Kalani M; Naserian S; Bidmeshkipour A
Gene; 2017 Sep; 627():327-336. PubMed ID: 28600182
[TBL] [Abstract][Full Text] [Related]
33. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4
He T; Chen Y; Yang D; Islam MS; Chou CK; Liu J; Faustman DL; Oppenheim JJ; Chen X
Cell Oncol (Dordr); 2023 Feb; 46(1):167-177. PubMed ID: 36369606
[TBL] [Abstract][Full Text] [Related]
34. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.
O'Connor RA; Leech MD; Suffner J; Hämmerling GJ; Anderton SM
J Immunol; 2010 Dec; 185(12):7235-43. PubMed ID: 21084662
[TBL] [Abstract][Full Text] [Related]
35. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
36. TNF receptor 2 signaling prevents DNA methylation at the
Tseng WY; Huang YS; Clanchy F; McNamee K; Perocheau D; Ogbechi J; Luo SF; Feldmann M; McCann FE; Williams RO
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21666-21672. PubMed ID: 31597740
[TBL] [Abstract][Full Text] [Related]
37. TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.
Chen X; Oppenheim JJ
Curr Dir Autoimmun; 2010; 11():119-34. PubMed ID: 20173391
[TBL] [Abstract][Full Text] [Related]
38. TNFR2 Signaling Enhances Suppressive Abilities of Human Circulating T Follicular Regulatory Cells.
Kawano S; Mitoma H; Inokuchi S; Yamauchi Y; Yokoyama K; Nogami J; Semba Y; Ayano M; Kimoto Y; Akahoshi M; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
J Immunol; 2022 Mar; 208(5):1057-1065. PubMed ID: 35149531
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
40. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
